Mylan N V (MYL) Holder Clearbridge LLC Has Upped Its Stake by $6.41 Million

May 17, 2018 - By Nellie Hooten

Mylan N.V. (NASDAQ:MYL) LogoInvestors sentiment increased to 3 in 2017 Q4. Its up 2.67, from 0.33 in 2017Q3. It increased, as 0 investors sold MYL shares while 1 reduced holdings. 3 funds opened positions while 0 raised stakes. 292,846 shares or 88.91% more from 155,019 shares in 2017Q3 were reported. Mirae Asset Glob Invests Co reported 17,231 shares or 0.01% of all its holdings. 120,545 were accumulated by Van Hulzen Asset Mngmt Llc. Gulf Natl Bank (Uk) Ltd holds 139,930 shares. Vantage Advsr Ltd Com holds 0% or 337 shares.

Clearbridge Llc increased its stake in Mylan N V (MYL) by 7.6% based on its latest 2017Q4 regulatory filing with the SEC. Clearbridge Llc bought 152,705 shares as the company’s stock declined 5.99% with the market. The institutional investor held 2.16 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $91.49M, up from 2.01M at the end of the previous reported quarter. Clearbridge Llc who had been investing in Mylan N V for a number of months, seems to be bullish on the $20.47B market cap company. The stock increased 1.48% or $0.58 during the last trading session, reaching $39.76. About 577,228 shares traded. Mylan N.V. (NASDAQ:MYL) has declined 5.23% since May 17, 2017 and is downtrending. It has underperformed by 16.78% the S&P500.

Clearbridge Llc, which manages about $5.40B and $4.80 billion US Long portfolio, decreased its stake in Bristol Myers Squibb Co (NYSE:BMY) by 426,980 shares to 565,980 shares, valued at $34.68 million in 2017Q4, according to the filing. It also reduced its holding in Qualcomm Inc (NASDAQ:QCOM) by 578,975 shares in the quarter, leaving it with 719,195 shares, and cut its stake in Realogy Hldgs Corp (NYSE:RLGY).

More important recent Mylan N.V. (NASDAQ:MYL) news were published by: which released: “Paulson’s 13F Shows New Stake in Goldcorp (GG), Increase in Discovery (DISCA), Viacom (VIAB) (more…)” on May 15, 2018, also published article titled: “Mylan NV (MYL) Q1 2018 Results – Earnings Call Transcript”, published: “Mylan NV Still Undervalued Despite Unveiling of New Products” on April 23, 2018. More interesting news about Mylan N.V. (NASDAQ:MYL) was released by: and their article: “Momenta Pharmaceuticals Contemplates Its Future” with publication date: May 15, 2018.

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

Among 14 analysts covering Mylan Inc (NASDAQ:MYL), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Mylan Inc had 20 analyst reports since December 4, 2017 according to SRatingsIntel. The firm has “Hold” rating by Cantor Fitzgerald given on Thursday, December 21. The stock of Mylan N.V. (NASDAQ:MYL) earned “Buy” rating by UBS on Thursday, March 1. Cantor Fitzgerald maintained Mylan N.V. (NASDAQ:MYL) on Thursday, March 1 with “Hold” rating. Citigroup maintained the stock with “Buy” rating in Thursday, January 4 report. The stock of Mylan N.V. (NASDAQ:MYL) earned “Buy” rating by Goldman Sachs on Thursday, January 11. The rating was maintained by Morgan Stanley with “Buy” on Monday, April 9. The rating was maintained by Mizuho on Thursday, January 18 with “Buy”. The rating was upgraded by Leerink Swann to “Outperform” on Thursday, April 12. BMO Capital Markets maintained Mylan N.V. (NASDAQ:MYL) rating on Tuesday, February 6. BMO Capital Markets has “Buy” rating and $50.0 target. The stock of Mylan N.V. (NASDAQ:MYL) earned “Overweight” rating by Morgan Stanley on Tuesday, March 6.

Mylan N.V. (NASDAQ:MYL) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.